Navigation Links
Finger prosthesis, standard, proximal

ProductsFinger prosthesis, standard, proximal
Company Mathys AG
Item Finger prosthesis, standard, proximal
Features 
  • Enables a near normal reconstruction of the natural function of the joint.
  • Contain a separable hinge with a longitudinal play of 0,7 mm, a lateral excursion of 10, and a rotation of approx. 6.
  • This configuration optimally weeds the functional requirements of the joint.
  • Particularly well suited for cases of chronic polyarthritis and traumatogenic joint replacement.
  • The distal and proximal joint components are coated with titanium.
  • A new coating method makes it possible to fix a perfectly adhering pure titanium layer to the joint surface in contact with bone.
Description The hands play an important part in our daily lives. But degenerative or traumatic impairments and rheumatic changes can cause severe handicaps. A decisive consideration in the developing of the finger-joint prostheses was to produce a reconstructed joint function that would reproduce the natural function as nearly possible. The cementless RM Finger System has proven itself in more than 30 years of clinical experiences worldwide. The first implantation, on 23 June 1970, was an interphalangeal joint of the thumb. The cementless finger joint prosthesis should enable a near normal reconstruction of the natural function of the joint. These prostheses have a separable hinge with a longitudinal play of 0,7 mm, a lateral excursion of 10, and a rotation of approx. 6. This configuration optimally weeds the functional requirements of the joint. This prothesis is particularly well suited for cases of chronic polyarthritis and traumatogenic joint replacement. The distal and proximal joint components are coated with titanium. A new coating method makes it possible to fix a perfectly adhering pure titanium layer to the joint surface in contact with bone. This improves the direct bony on-growth of the prosthesis.
Info Mathys AG
Customer Service: +41 (0)32 644 1 644
Web site: http://www.mathysmedical.com/index.php?id=1&L=1

Related medicine products :

1. MicroFinger Irrigating Nucleus Chopper
2. Cervical Retractor With Double Finger Hold
3. NeuFlex™ MCP/PIP Finger Joint Implant Systems
4. Swanson Finger Joint Implants
5. Swanson Finger Pins
6. Finger Clip Electrodes
7. Finger prosthesis, small, proximal
8. Finger prosthesis, long, proximal
9. Finger prosthesis, small, distal
10. Finger prosthesis, standard/long, distal
11. Five Finger Fan Retractor
Other Medicine News:Health News:DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group 2Health News:DiagnoCure's GCC marker for the staging of colorectal cancer discussed at the Eastern Cooperative Oncology Group 3Health News:SXC Health Solutions announces informedRx renewal contract with The University of Michigan 2Health News:Samplify Systems Announces Distribution Agreement With Tokyo Electron Device Limited, Broadening Availability of Signal Compression Technology 2Health News:Breastfeeding.com Launches First Ever Social Network for Birth-Related Medical Professionals 2Health News:Womenshealthchannel Enhancements Support Pregnant Teens 2Health News:Womenshealthchannel Enhancements Support Pregnant Teens 3Health News:Womenshealthchannel Enhancements Support Pregnant Teens 4Health News:Womenshealthchannel Enhancements Support Pregnant Teens 5Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 2Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 3Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 4Health News:Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems 5
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New Evidence Supports HPV Vaccine 50832 1New Evidence Supports HPV Vaccine 50832 2Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 1Pelosi Remarks on Economic Recovery Act at Mission Neighborhood Health Center in San Francisco 50830 2Carbohydrate acts as tumor suppressor 50828 1Carbohydrate acts as tumor suppressor 50828 2